Eli Lilly and Company (LLY) Guidance & Earnings Results
On 2026-08-05 Eli Lilly and Company raised guidance: "Revenue guidance raised to $85-87B; non-GAAP EPS guidance raised by $2.78 at midpoint (before IPR&D…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LLYEli Lilly and CompanyFollow LLY — free
—
Price chart with a free account
- Market cap
- 1.20T
- P/E TTM
- 42.7
- Dividend yield
- 0.5%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 5 Aug 26 | Raised | Revenue guidance raised to $85-87B; non-GAAP EPS guidance raised by $2.78 at midpoint (before IPR&D offset) · full year |
| 30 Apr 26 | Raised | FY2026 revenue guidance raised to $82-85B (up $2B); non-GAAP EPS guidance raised to $35.50-37.00 · full year |
| 4 Feb 26 | Raised | Revenue guidance $80-83 billion for FY2026; non-GAAP EPS $33.50-35.00. · full year |
| 30 Oct 25 | Raised | Revenue guidance raised to $63.0-$63.5B; non-GAAP EPS raised to $23.00-$23.70 · full year |
| 7 Aug 25 | Raised | FY2025 revenue raised to $60-62B from $58.5-60.5B; reported EPS $20.85-22.10; non-GAAP EPS $21.75-23.00 · full year |
Eli Lilly and Company — questions
- What guidance did Eli Lilly and Company give?
- On 2026-08-05: "Revenue guidance raised to $85-87B; non-GAAP EPS guidance raised by $2.78 at midpoint (before IPR&D offset)"
- When does Eli Lilly and Company report earnings?
- Eli Lilly and Company's next earnings report is expected on 2026-10-29.
Every figure on this page comes from Eli Lilly and Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.